Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Consulting agrmnt
Auditor change
Credit agrmnt [a]
Director departure
Employment agrmnt
|
|
HORIZON PHARMACEUTICAL LLC (RPTP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/31/2016 |
8-K
| Quarterly results |
| 10/25/2016 |
8-K
| Form 8-K - Current report |
| 10/19/2016 |
8-K
| Form 8-K - Current report |
| 10/11/2016 |
8-K
| Form 8-K - Current report |
| 09/12/2016 |
8-K
| Form 8-K - Current report |
| 08/04/2016 |
8-K
| Form 8-K - Current report |
| 07/07/2016 |
8-K
| Form 8-K - Current report |
| 05/27/2016 |
8-K
| Form 8-K - Current report |
| 05/13/2016 |
8-K
| Form 8-K - Current report |
| 05/05/2016 |
8-K
| Form 8-K - Current report |
| 03/15/2016 |
8-K
| Form 8-K - Current report |
| 02/25/2016 |
8-K
| Quarterly results |
| 02/09/2016 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 12/10/2015 |
8-K
| Other Events, Financial Statements and Exhibits |
| 11/05/2015 |
8-K
| Quarterly results |
| 10/05/2015 |
8-K
| Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity ... |
| 09/14/2015 |
8-K
| Other Events, Financial Statements and Exhibits |
| 09/09/2015 |
8-K
| Other Events, Financial Statements and Exhibits |
| 09/04/2015 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
| 09/04/2015 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits|
Docs:
|
"ASSET PURCHASE AGREEMENT between: RAPTOR PHARMACEUTICAL CORP., a Delaware corporation; and TRIPEX PHARMACEUTICALS, LLC, a Delaware limited liability company Dated as of August 20, 2015 [***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission Confidential treatment has been requested with respect to portions of this agreement. CONFIDENTIAL TABLE OF CONTENTS Section Page 1. Sale of Transferred Assets and Related Matters 1 1.1 Sale of Transferred Assets 1 1.2 Excluded Assets 2 1.3 Purchase Price 2 1.4 Assumption of Certain Liabilities 3 1.5 Issuances of Purchaser Common Stock 4 1.6 Transaction Taxes 6 1.7 Allocation 6 1.8 Tax Withholding 6 1.9 Closing 7 2. Contingent Consideration 7 2.1 Milestone Payments 7 2.2 Revenue-Based ...",
"Registration Rights Agreement, by and among Raptor Pharmaceutical Corp., Tripex Pharmaceuticals, LLC and certain members of Tripex Pharmaceuticals, LLC",
"Registration Rights Agreement, by and among Raptor Pharmaceutical Corp., Tripex Pharmaceuticals, LLC and certain members of Tripex Pharmaceuticals, LLC",
"COMMERCIAL SUPPLY AGREEMENT This COMMERCIAL SUPPLY AGREEMENT , dated as of August 20, 2015 , is made between PARI PHARMA GMBH, a German corporation, with a principal place of business at Moosstrasse 3, D-82319 Starnberg, Germany , and RAPTOR PHARMACEUTICALS, INC., a Delaware corporation, with a place of business at 7 Hamilton Landing, Suite 100, Novato, CA 94949 . PARI and RAPTOR are sometimes referred to herein individually as a “Party” and collectively as the “Parties.” RECITALS WHEREAS, PARI is in the business of developing, manufacturing and commercializing, among other things, drug inhalation devices and optimized formulations used in the treatment of respiratory tract disorders. WHEREAS, RAPTOR is in the business of developing and commercializing drugs for various diseases and condit...",
"LETTER AGREEMENT This Letter Agreement dated as of August 20, 2015, is made by and between PARI PHARMA GMBH, a company organized under the laws of Germany , and RAPTOR PHARMACEUTICALS, INC., a Delaware corporation . RECITALS A. PARI GmbH, an affiliate of PARI, and MPEX Pharmaceuticals, Inc. entered into a Development and License Agreement, effective as of February 11, 2006 . The Development Agreement was subsequently assigned by PARI GmbH to PARI. B. RAPTOR is in the process of, either directly or through an affiliate, acquiring all of the assets and certain obligations of TRIPEX Pharmaceuticals, LLC, a Delaware limited liability company , including the Development Agreement . C. RAPTOR and PARI are entering into a new Supply Agreement as a condition of RAPTOR's execution of the purchase a...",
"TO THE DEVELOPMENT AND LICENSE AGREEMENT" |
|
| 08/21/2015 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Stat... |
| 08/06/2015 |
8-K
| Quarterly results |
| 07/16/2015 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/20/2015 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/18/2015 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits |
| 05/07/2015 |
8-K
| Quarterly results |
| 04/03/2015 |
8-K
| Other Events, Financial Statements and Exhibits |
| 02/26/2015 |
8-K
| Quarterly results |
| 02/13/2015 |
8-K
| Shareholder Nominations Pursuant to Exchange Act Rule 14a-11, Other Events |
| 01/07/2015 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 12/18/2014 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 11/06/2014 |
8-K
| Quarterly results |
| 10/23/2014 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 08/21/2014 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
|
|
|